EYPT
EyePointBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
EYPT vs peer average
76/100
EYPT vs. peer average (B vs. D)
Grade spread
C 5 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
OCUL is the first available peer comparator.
Ocular Therapeutix is the clearest direct retinal sustained-delivery comparator; EyePoint's own 10-K highlights Ocular's AXPAXLI Phase 3 wet AMD and NPDR programs, underscoring competitive timing risk if EyePoint stumbles.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EYPT
EyePoint
OCUL
Ocular Therapeutix
Grade
B
C
Momentum
61
37
Value
41
41
Sentiment
67
83
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs OCUL
EYPT / OCUL
Grade Position
Above peers
EYPT vs. peer average (B vs. D)
76/100
Momentum
61
EYPTValue
41
EYPTSentiment
67
OCULRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EYPT
OCUL is the first peer returned for this comparison set.